KDXC(002669)

Search documents
康达新材: 2025年半年度业绩预告
Zheng Quan Zhi Xing· 2025-07-13 08:13
Performance Forecast - The company expects a net profit of 50 million to 55 million yuan for the period from January 1, 2025, to June 30, 2025, compared to a loss of 56.511 million yuan in the same period last year, indicating a growth of 188.48% to 197.33% year-on-year [1] - The net profit after deducting non-recurring gains and losses is projected to be between 39.0976 million and 44.0976 million yuan, up from a loss of 59.4986 million yuan in the previous year, reflecting a growth of 165.71% to 174.12% [1] - The basic earnings per share are expected to be between 0.168 yuan and 0.184 yuan, compared to a loss of 0.190 yuan per share last year [1] Reasons for Performance Change - The increase in net profit is attributed to the steady growth in sales volume of specialty resin new materials, particularly driven by strong demand for wind turbine blade products due to the improving conditions in the wind power industry [2] - The company's enhanced profitability is also supported by cost control measures and other initiatives [2] - Additional income from equity investments, government subsidies, and dividends from associated companies contributed to the overall performance [2]
康达新材(002669) - 2025 Q2 - 季度业绩预告
2025-07-13 07:35
[Kangsda New Material 2025 Semi-Annual Performance Forecast](index=1&type=section&id=%E5%BA%B7%E8%BE%BE%E6%96%B0%E6%9D%90%E6%96%99%EF%BC%88%E9%9B%86%E5%9B%A2%EF%BC%89%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B82025%E5%B9%B4%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A) [Core Performance Forecast Data](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E8%AE%A1%E6%83%85%E5%86%B5) The company anticipates a significant turnaround to profitability in H1 2025, with net profit attributable to shareholders projected between RMB 50 million and RMB 55 million Key Performance Forecast Data | Item | Current Reporting Period (2025 H1) | Prior Period (2024 H1) | Year-on-Year Change | | :--- | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | Profit: RMB 50.00 million – RMB 55.00 million | Loss: RMB 56.51 million | Growth: 188.48%–197.33% | | **Net Profit After Deducting Non-Recurring Gains/Losses** | Profit: RMB 39.10 million – RMB 44.10 million | Loss: RMB 59.50 million | Growth: 165.71%–174.12% | | **Basic Earnings Per Share** | Profit: RMB 0.168/share – RMB 0.184/share | Loss: RMB 0.190/share | Turned Loss into Profit | [Communication with Accounting Firm](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8E%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%B2%9F%E9%80%9A%E6%83%85%E5%86%B5) The company has pre-communicated with its accounting firm regarding the performance forecast, with no major disagreements, though the data remains unaudited - The performance forecast data are preliminary and unaudited by the accounting firm, but the company has pre-communicated with them on relevant matters, with no significant disagreements[4](index=4&type=chunk) [Analysis of Performance Change Reasons](index=1&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) The turnaround to profitability is primarily driven by core business growth, enhanced operational efficiency, and positive non-recurring gains and losses - Core business growth: The total sales volume of adhesive and special resin new material products steadily increased, with strong demand for wind power blade series products due to improved industry prosperity, becoming a primary driver for performance growth[5](index=5&type=chunk) - Enhanced profitability: The company improved its profitability through measures such as optimizing resource allocation, enhancing asset operational efficiency, and reducing management costs[5](index=5&type=chunk)[6](index=6&type=chunk) - Non-recurring gains and losses: During the reporting period, the company's non-recurring gains and losses are estimated at **RMB 11 million**, primarily from investment income generated by the disposal of subsidiary equity, government subsidies received, and dividends from associate companies[6](index=6&type=chunk) [Risk Warning](index=2&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) Investors are cautioned that this unaudited performance forecast is preliminary, and final financial results will be subject to the 2025 semi-annual report - This performance forecast is a preliminary estimate by the company's finance department and is unaudited; final data will be subject to the company's 2025 semi-annual report, so investors are advised to exercise caution[7](index=7&type=chunk)
康达新材: 关于关联方对全资孙公司增资暨公司放弃优先认缴出资权的关联交易公告
Zheng Quan Zhi Xing· 2025-07-09 16:23
Overview - The company, Kangda New Materials (Group) Co., Ltd., is conducting a capital increase for its wholly-owned subsidiary, Chengdu Kangda Jinrui Technology Co., Ltd., to meet operational funding needs and enhance capital strength [1][12]. Capital Increase Details - The total capital increase amounts to RMB 116.67 million, with Tianjin Tangkong Kechuang Group Co., Ltd. contributing RMB 66.67 million for a 40% stake, and Shanghai Fengfan Jingying Industrial Material Supply Co., Ltd. contributing RMB 50 million for a 30% stake [1][9]. - After the capital increase, the registered capital of Kangda Jinrui will rise from RMB 50 million to RMB 166.67 million [2][12]. Related Party Transactions - Both investors are related parties, as Tangkong Kechuang is controlled by the company's major shareholder, Tangshan Industrial Holding Group Co., Ltd., and Fengfan Jingying is a wholly-owned subsidiary of Tangshan Industrial Holding Group [2][12]. - The board of directors approved the transaction, with related directors abstaining from voting, and independent directors held a special meeting to agree on the transaction [2][12]. Financial Impact - The capital increase will not significantly impact the company's financial status or operating results, as Kangda Jinrui will no longer be included in the consolidated financial statements after the company waives its preemptive rights [12]. - The transaction pricing is deemed fair and does not harm the interests of minority shareholders [12]. Independent Review - The independent directors unanimously agreed to the proposal, stating it aligns with the company's strategic development needs and optimizes asset structure and resource allocation [12].
康达新材(002669) - 关于关联方对全资孙公司增资暨公司放弃优先认缴出资权的关联交易公告
2025-07-09 11:15
证券代码:002669 证券简称:康达新材 公告编号:2025-085 康达新材料(集团)股份有限公司 关于关联方对全资孙公司增资暨公司放弃优先认缴出资权 的关联交易公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、本次交易事项概述 1、关联交易的基本情况 为满足康达新材料(集团)股份有限公司(以下简称"公司"或"康达新材") 全资孙公司成都康达锦瑞科技有限公司(以下简称"康达锦瑞")运营的资金需求, 增强其资本实力,拟增资扩股引入公司关联方天津唐控科创集团有限公司(以下 简称"唐控科创")、上海风范晶樱工业物资供应有限公司(以下简称"风范晶樱") 对康达锦瑞进行增资,合计增资人民币11,666.6667万元,其中,唐控科创以现金 方式增资人民币6,666.6667万元,增资后持有康达锦瑞40%的股权;风范晶樱以 现金方式增资人民币5,000万元,增资后持有康达锦瑞30%的股权。公司全资子公 司北京康达晟璟集成电路(集团)有限公司(以下简称"康达集成电路")作为 康达锦瑞原股东对唐控科创和风范晶樱增资部分将放弃优先认缴出资权。 本次增资完成后,康达锦瑞 ...
康达新材(002669) - 第六届董事会第七次会议决议公告
2025-07-09 11:15
证券代码:002669 证券简称:康达新材 公告编号:2025-084 康达新材料(集团)股份有限公司 第六届董事会第七次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 二、董事会会议审议情况 康达新材料(集团)股份有限公司(以下简称"公司")第六届董事会第七 次会议通知于2025年7月3日以邮件及通讯方式向公司董事发出。经全体董事书面 同意,会议于2025年7月8日上午9:30在上海市浦东新区五星路707弄御河企业公 馆A区3号楼公司会议室以现场结合通讯表决方式召开,应出席董事13人,实际出 席董事13人,全体董事以通讯方式参加会议,参与表决的董事13人。本次会议由 董事长王建祥主持,公司董事会秘书列席了本次会议,会议的通知、召集、召开 和表决程序符合《公司法》及《公司章程》的规定。 1、审议通过《关于关联方对全资孙公司增资暨公司放弃优先认缴出资权的 关联交易议案》 具体内容详见公司刊登在巨潮资讯网及《证券时报》《证券日报》《上海证 券报》《中国证券报》的《关于关联方对全资孙公司增资暨公司放弃优先认缴出 资权的关联交易公 ...
康达新材(002669) - 2025年7月8日投资者关系活动记录表
2025-07-08 10:08
Business Overview - Kangda New Materials is a leading fine chemical enterprise in China, specializing in high-end adhesives and polymer new materials, with over 30 years of technological accumulation and innovation [2]. - The company maintains the largest market share in the domestic market for wind turbine blade structural adhesives [2][3]. Wind Power Sector Performance - In 2024, the sales volume of wind turbine blade epoxy structural adhesives exceeded 40,000 tons, while epoxy infusion resin sales reached 45,000 tons, showing steady growth over three consecutive years [3]. - In Q1 2025, the company continued to lead the industry in sales of wind turbine blade epoxy structural adhesives [3]. Core Competitiveness - The company has nearly 300 authorized patents and several industry standards, supported by a national enterprise technology center [4]. - It has established a strong customer base and received multiple industry honors and certifications, ensuring product quality recognition [4]. Financial Performance - In Q1 2025, the net profit attributable to shareholders reached 6.3718 million yuan, a 125.70% increase compared to the same period last year, driven by significant revenue growth and improved operational efficiency [5]. Acquisition Strategy - The company intends to acquire Chengdu Zhongke Huamei Electronics Co., Ltd., a high-tech enterprise specializing in integrated circuit products, to expand into the semiconductor integrated circuit field [6][7]. - This acquisition aims to enhance profitability and operational sustainability by integrating quality assets in the special integrated circuit design and testing sectors [7]. R&D and Product Development - The company is developing aluminum oxide targets and CMP (Chemical Mechanical Polishing) slurries for semiconductor manufacturing, with ongoing internal testing [7]. - Its subsidiary, Dalian Qihua, specializes in high-quality epoxy resin production, serving various industries including new energy and aerospace [7]. International Expansion - The establishment of a new adhesive materials production base in Thailand aims to meet overseas customer demands and enhance international business operations [8]. - The company is actively expanding its overseas market presence, particularly in Southeast Asia, Central Asia, and South Asia, leveraging its core product advantages [8].
新股发行及今日交易提示-20250707





HWABAO SECURITIES· 2025-07-07 10:41
New Stock Issuance - Huadian New Energy (证券代码: 730930) issued shares at a price of 3.18 on July 7, 2025[1] - Jichuan Pharmaceutical (证券代码: 600566) has a tender offer period from June 18 to July 17, 2025[1] - ST Yazhen (证券代码: 603389) has a tender offer period from June 10 to July 9, 2025[1] Trading Alerts - The last trading day for TSM Jinguang (证券代码: 600190) is in 9 trading days[1] - The last trading day for TSM Jinyou (证券代码: 600462) is in 5 trading days[1] - The last trading day for TSM Gongzhi (证券代码: 000584) is in 3 trading days[1] Abnormal Fluctuations - Northern Long (证券代码: 301357) is experiencing severe abnormal fluctuations[1] - ST Dongjing (证券代码: 002199) reported abnormal fluctuations[3] - ST Yunchuang (证券代码: 835305) reported abnormal fluctuations on July 4, 2025[3]
康达新材(002669) - 2025年第三次临时股东会决议公告
2025-07-04 11:00
证券代码:002669 证券简称:康达新材 公告编号:2025-083 康达新材料(集团)股份有限公司 2025年第三次临时股东会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 特别提示 1、本次股东会没有出现否决议案的情形; 2、本次股东会不涉及变更以往股东会已通过的决议; 3、本次股东会采取现场投票与网络投票相结合的方式召开; 4、康达新材料(集团)股份有限公司(以下简称"公司")于2023年4月28 日召开的第五届董事会第二十一次会议和第五届监事会第十八次会议审议通过 了《关于回购公司股份方案(第七期)的议案》,决定使用自有资金以集中竞价 方式回购公司股份,公司已于2023年12月19日,完成了本次回购公司股份事宜, 并将部分回购股份用于实施员工持股计划和注销。公司于2025年1月17日召开的 第五届董事会第四十次会议和第五届监事会第三十二次会议审议通过了《关于回 购公司股份方案(第八期)的议案》,决定使用自有资金及金融机构股票回购专 项贷款资金以集中竞价方式回购公司股份,公司已于2025年5月31日,完成了本 次回购公司股份事宜,回购股份存放 ...
康达新材(002669) - 北京植德(上海)律师事务所关于康达新材料(集团)股份有限公司2025年第三次临时股东会的法律意见书
2025-07-04 10:47
北京植德(上海)律师事务所 关于康达新材料(集团)股份有限公司 2025 年第三次临时股东会的 法律意见书 植德沪(会)字[2025]0030 号 二〇二五年七月 上海市徐汇区虹桥路 183 号徐家汇中心三期 A 座办公楼 27 层(THREE itc) 邮编:200030 27th Floor Tower A, THREE itc, No.183 Hongqiao Road, Xuhui District, Shanghai 200030 P.R.C 电话(Tel):021-52533500 传真(Fax):021-52533599 www.meritsandtree.com 北京植德(上海)律师事务所 关于康达新材料(集团)股份有限公司 2025 年第三次临时股东会的 法律意见书 植德沪(会)字[2025]0030 号 致:康达新材料(集团)股份有限公司(贵公司) 北京植德(上海)律师事务所(以下简称"本所")接受贵公司的委托,指派 律师出席并见证贵公司 2025 年第三次临时股东会(以下简称"本次会议")。 本所律师根据《中华人民共和国公司法》(以下简称"《公司法》")、《中 华人民共和国证券法》(以下 ...
新股发行及今日交易提示-20250703





HWABAO SECURITIES· 2025-07-03 09:09
New Stock Offerings - Jichuan Pharmaceutical (600566) has a tender offer period from June 18, 2025, to July 17, 2025[1] - *ST Yazhen (603389) has a tender offer period from June 10, 2025, to July 9, 2025[1] - Zhongcheng Tui (300208) has 11 trading days remaining until the last trading day[1] Delisting and Trading Reminders - Tui Shi Jin Gang (600190) has 11 trading days remaining until the last trading day[1] - Hengli Tui (000622) is in the delisting arrangement period with 8 trading days remaining[1] - Tui Shi Jiu You (600462) has 7 trading days remaining until the last trading day[1] Market Volatility - Beifang Changlong (301357) reported severe abnormal fluctuations[1] - Multiple companies, including Jichuan Pharmaceutical and *ST Yazhen, are under scrutiny for trading anomalies[1]